Pulmonary Hypertension in the Era of Mechanical Circulatory Support

about

Pulmonary Hypertension in the Era of Mechanical Circulatory Support

Item

http://www.wikidata.org/entity/Q38904366

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pulmonary Hypertension in the Era of Mechanical Circulatory Support

@en

type

Item

label

Pulmonary Hypertension in the Era of Mechanical Circulatory Support

@en

prefLabel

Pulmonary Hypertension in the Era of Mechanical Circulatory Support

@en

P1476

Pulmonary Hypertension in the Era of Mechanical Circulatory Support

@en

P2093

Adrian F Hernandez

http://www.w3.org/2001/XMLSchema#string

Carmelo A Milano

http://www.w3.org/2001/XMLSchema#string

Chetan B Patel

http://www.w3.org/2001/XMLSchema#string

Joseph G Rogers

http://www.w3.org/2001/XMLSchema#string

Kishan S Parikh

http://www.w3.org/2001/XMLSchema#string

Lauren B Cooper

http://www.w3.org/2001/XMLSchema#string

Yamini Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

P2860

The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.

Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.

Diagnosis and assessment of pulmonary arterial hypertension.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.

P304

505-512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MAT.0000000000000408

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gary Felker

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27442856

http://www.w3.org/2001/XMLSchema#string

P932

5001897

http://www.w3.org/2001/XMLSchema#string